Invesco S&P SmallCap Health Care ETF
Price through Oct 2 · Flows through Oct 1. Figures use the latest available records, not a live quote. Fund details retrieved Oct 2. Holdings snapshot retrieved Oct 2.
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 6M SHOWN · NET +$23M OVER THIS RANGE
Money keeps arriving — +$1M of net inflows over the past month, about 0.6% of the fund's asset base, while the price has returned +17.2% so far this year. At 0.29% a year it is not the cheapest way in — AVIE has a reported fee of 0.25%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | GKOSGLAUKOS | 5.26% | $163.75 | +0.4% | ||
| 2 | PTGXPROTAGONIST THERAPEUTICS | 4.93% | $140.06 | +0.6% | ||
| 3 | TGTXTG THERAPEUTICS | 4.16% | $54.29 | +1.2% | ||
| 4 | ALKSALKERMES | 3.72% | $41.75 | +3.0% | ||
| 5 | LGNDLIGAND PHARMACEUTICALS | 3.30% | $302.96 | +0.1% | ||
| 6 | PTCTPTC THERAPEUTICS | 2.93% | $63.46 | -1.0% | ||
| 7 | TFXTELEFLEX | 2.92% | $124.12 | -1.6% | ||
| 8 | MMSIMERIT MEDICAL SYSTEMS | 2.81% | $85.37 | -0.9% | ||
| 9 | RDNTRADNET | 2.62% | $69.93 | +3.3% | ||
| 10 | ITGRINTEGER HOLDINGS | 2.35% | $126.45 | +0.0% | ||
| 11 | CONCONCENTRA GROUP HOLDINGS PARENT INC | 2.27% | $35.65 | +1.9% | ||
| 12 | INDVINDIVIOR | 2.28% | $35.71 | +0.9% | ||
| 13 | ICUIICU MEDICAL | 2.15% | $159.38 | +1.4% | ||
| 14 | AMRXAMNEAL PHARMACEUTICALS | 2.02% | $20.30 | +1.1% | ||
| 15 | VCYTVERACYTE | 1.94% | $45.81 | +3.7% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 66| 1 week | -2.2% |
| 1 month | -5.9% |
| 3 months | -4.0% |
| 6 months | +25.5% |
| YTD | +17.2% |
| 1 year | +22.3% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$3M |
| 1 month | +$1M |
| 3 months | +$20M |
| YTD | +$5M |
| 1 year | +$5M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 5.3% of the book; the top ten carry 35%. Spread across 71+ names, it behaves like roughly 46 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LQDA LIQUIDIA | $3M | $3M |
| SDGR SCHRODINGER | $1M | $1M |
| TMDX TRANSMEDICS GROUP | $2M | $518,114 |
| ALKS ALKERMES | $99,522 | $1M |
| TGTX TG THERAPEUTICS | $594,031 | $203,816 |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PSCH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -26bp on fee · 238× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -26bp on fee · 105× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $122.8B | +$2.3B | -24bp on fee · 706× the assets · +$2.3B in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -25bp on fee · 189× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -25bp on fee · 136× the assets · +$575M in over the month | Head-to-head |